wistar institute
Targeted cancer therapies can suppress T cell immune responses, study finds
March 23, 2016Research and Development T cell, anti-cancer drugs, immunosuppresive, superagonist, wistar institute
Researchers at the Wistar Institute have developed a new method whereby targeted cancer therapies can provide appropriate therapeutics without supressing …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
